Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 7/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.32 |
| ▸ | IDH1 | O75874 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3572528 | 0.85 | ALOX5 (0.41) | ALOX5KMT2APIK3CD | |
| SCHEMBL3567445 | 0.81 | ALOX5 (0.43) | ALOX5KMT2APIK3CD | |
| SCHEMBL3561984 | 0.79 | ALOX5 (0.43) | ALOX5KMT2APIK3CD | |
| SCHEMBL7892149 | 0.78 | ALOX5 (0.42) | ALOX5KMT2A | |
| SCHEMBL7811821 | 0.73 | ALOX5 (0.42) | ALOX5KMT2APIK3CD | |
| SCHEMBL1599579 | 0.72 | ALOX5 (0.36) | ALOX5KMT2APIK3CD | |
| SCHEMBL1599433 | 0.72 | ALOX5 (0.35) | ALOX5PIK3CD | |
| SCHEMBL7809060 | 0.72 | KMT2A (0.41) | ALOX5KMT2APIK3CD | |
| SCHEMBL1599036 | 0.72 | ALOX5 (0.38) | ALOX5KMT2APIK3CD | |
| SCHEMBL1599332 | 0.71 | ALOX5 (0.39) | ALOX5CYP11B2PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7674811-B2 | 5-lipoxygenase inhibitors | RANBAXY LABORATORIES LIMITED (IN) | 2010-03-09 | — | — | US | disclosed |
| US-20080021080-A1 | 5-LIPOXYGENASE INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2008-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021080-A1 | 5-LIPOXYGENASE INHIBITORS | ALOX5, ALOX15B, ALOX15 | ALOX5 1/4885CYP11B2 410/4885KMT2A 4105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.